AWE TV Documentary “Marijuana, Miracle Cure 3: Journey to Health” Showcases Three Distinctly Different Consumer Profiles, Network Viewership Estimated at 16.2 Million
SAN DIEGO, Aug. 25, 2014 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is honored that AWE TV selected industrial hemp-based cannabidiol (CBD) as the focal point of the third part of its popular series “Marijuana, Miracle Cure 3: Journey to Health.” The latest show aired Sunday, August 24th through AWE TV’s network of cable television providers reaching an audience of 16.2 million worldwide. “Journey to Health” will re-broadcast on Friday and Saturday night, Sept. 5th and 6th. Check AWE’s cable network for show times. AWE TV broadcasts also stream live through ROKU™, Boxee™, Samsung™ connected TVs, Panasonic™ 2011+ connected TVs and 3D content on VUDU.
“The footage that AWE TV shares in ‘Journey to Health‘ is historic,” states Michelle Sides, Chief Operating Officer of Medical Marijuana, Inc. “Through this informational broadcast, awareness of industrial hemp’s versatility and enormous global economic potential is rapidly shifting to that of worldwide acceptance. We are extremely appreciative to AWE TV for setting the record straight on the history of the cannabis plant and the extreme differences in its varieties.”
In “Journey to Health,” AWE TV compared varieties of the cannabis plant species for viewers. The example contrasted cats in the feline species: a cheetah is to “marijuana” that is laden with THC (the cannabinoid that makes people “high”) as a domestic house cat is to cannabidiol or “CBD,” another naturally occurring cannabinoid in the plant with no psychotropic and counteractive effects to THC.
Sides adds, “Medical Marijuana, Inc. believes in ‘access for all’ to the ‘whole plant.’ Yet, when viewers on a national scale learn more about the Company, the power of making CBD from the industrial hemp plant available to the masses becomes much clearer.”
The eco-friendly industrial hemp plant grows five to six times faster than any other crop in one season without the need for herbicides or pesticides. Sides continues, “From the European farmers who grow our proprietary cultivars and all of the governmental agencies who monitor the process of importing raw CBD-rich hemp oil, to the world’s leading scientists, laboratories, formulators, manufacturers, marketing and customer service agents who engage daily with consumers of all ages, it has been a real labor of love and years in the making for the Company to arrive at where we are today.”
In the US, there are 23 “legal” medical marijuana states, along with the District of Columbia. If one considers CBD’s origin from the “marijuana plant,” access may be limited to just those states. However, it is key to understand that product lines provided by Medical Marjuana, Inc.’s subsidiaries are already available online. These innovative CBD-rich hemp oil products ship to all 50 states and more than 40 countries without any “red tape.”
Sides continues, “We are extremely proud that the Company’s efforts garnered the attention of AWE TV. Through their groundbreaking documentary, the world is getting a deeper understanding of the uniqueness of industrial hemp-derived CBD. We are also very excited to announce that the products featured in ‘Journey to Health‘ are just a fraction of the new CBD-rich hemp oil products that will soon be available online and on retail store shelves.”
The Company invites the public to get involved in the conversation about CBD-rich hemp oil available through its subsidiaries by posting to the Company’s social media channels, including Facebook and Twitter.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell, and distribute hemp-based products and is involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Media relations contact:
Director of Public Relations